GSDMA and breast carcinoma: However, treatment with 5-aza-2’-deoxycytidine (5-aza-dC), a DNA methyltransferase inhibitor, could upregulate the expression of GSDMA but not GSDMB in the MCF7 cell [37], indicating that GSDMA expression is mediated by DNA methylation in breast cancer.